The Role of Immune Cells and Associated Immunological Factors in the Immune Response to Spinal Cord Injury

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2023 Jan 23

PMID 36685599

Authors

Huaguo Tang

Yuanjie Gu

Lei Jiang

Gang Zheng

Zhuoer Pan

Xiugui Jiang

Affiliations

Soon will be listed here.

Abstract

Spinal cord injury (SCI) is a devastating neurological condition prevalent worldwide. Where the pathological mechanisms underlying SCI are concerned, we can distinguish between primary injury caused by initial mechanical damage and secondary injury characterized by a series of biological responses, such as vascular dysfunction, oxidative stress, neurotransmitter toxicity, lipid peroxidation, and immune-inflammatory response. Secondary injury causes further tissue loss and dysfunction, and the immune response appears to be the key molecular mechanism affecting injured tissue regeneration and functional recovery from SCI. Immune response after SCI involves the activation of different immune cells and the production of immunity-associated chemicals. With the development of new biological technologies, such as transcriptomics, the heterogeneity of immune cells and chemicals can be classified with greater precision. In this review, we focus on the current understanding of the heterogeneity of these immune components and the roles they play in SCI, including reactive astrogliosis and glial scar formation, neutrophil migration, macrophage transformation, resident microglia activation and proliferation, and the humoral immunity mediated by T and B cells. We also summarize findings from clinical trials of immunomodulatory therapies for SCI and briefly review promising therapeutic drugs currently being researched.

Citing Articles

Zinc regulates microglial polarization and inflammation through IKBα after spinal cord injury and promotes neuronal repair and motor function recovery in mice.

Li D, Bai M, Guo Z, Cui Y, Mei X, Tian H Front Pharmacol. 2025; 16:1510372.

PMID: 39944615 PMC: 11813752. DOI: 10.3389/fphar.2025.1510372.

Machine Learning and Experiments Revealed Key Genes Related to PANoptosis Linked to Drug Prediction and Immune Landscape in Spinal Cord Injury.

Li B, Li T, Cai Y, Cheng J, Zhang C, Liu J Mol Neurobiol. 2025; .

PMID: 39888480 DOI: 10.1007/s12035-025-04717-8.

Integrated bioinformatics analysis identified cuproptosis-related hub gene Mpeg1 as potential biomarker in spinal cord injury.

Mao D, Chen Q, Tong S, Xu Z, Yu G, Chang C Sci Rep. 2025; 15(1):1993.

PMID: 39814871 PMC: 11736097. DOI: 10.1038/s41598-025-86170-0.

Lentivirus-mediated Knockdown of Ski Improves Neurological Function After Spinal Cord Injury in Rats.

Wang Z, Ran R, Ma C, Zhao G, Zhou K, Zhang H Neurochem Res. 2024; 50(1):15.

PMID: 39549172 DOI: 10.1007/s11064-024-04261-2.

Meta-analysis of the efficacy of the erector spinae plane block after spinal fusion surgery.

He Y, Liu H, Ma P, Zhang J, He Q PeerJ. 2024; 12:e18332.

PMID: 39494287 PMC: 11531255. DOI: 10.7717/peerj.18332.

References

Wang X, Zhang Z, Zhu Z, Liang Z, Zuo X, Ju C . Photobiomodulation Promotes Repair Following Spinal Cord Injury by Regulating the Transformation of A1/A2 Reactive Astrocytes. Front Neurosci. 2021; 15:768262. PMC: 8593167. DOI: 10.3389/fnins.2021.768262. View

Gottipati M, DAmato A, Ziemba A, Popovich P, Gilbert R . TGFβ3 is neuroprotective and alleviates the neurotoxic response induced by aligned poly-l-lactic acid fibers on naïve and activated primary astrocytes. Acta Biomater. 2020; 117:273-282. PMC: 8645246. DOI: 10.1016/j.actbio.2020.09.057. View

Chio J, Wang J, Badner A, Hong J, Surendran V, Fehlings M . The effects of human immunoglobulin G on enhancing tissue protection and neurobehavioral recovery after traumatic cervical spinal cord injury are mediated through the neurovascular unit. J Neuroinflammation. 2019; 16(1):141. PMC: 6615094. DOI: 10.1186/s12974-019-1518-0. View

Xu P, Zhang F, Chang M, Zhong C, Sun C, Zhu H . Recruitment of γδ T cells to the lesion via the CCL2/CCR2 signaling after spinal cord injury. J Neuroinflammation. 2021; 18(1):64. PMC: 7927238. DOI: 10.1186/s12974-021-02115-0. View

Huang H, Young W, Skaper S, Chen L, Moviglia G, Saberi H . Clinical Neurorestorative Therapeutic Guidelines for Spinal Cord Injury (IANR/CANR version 2019). J Orthop Translat. 2020; 20:14-24. PMC: 6939117. DOI: 10.1016/j.jot.2019.10.006. View

Mohrman A, Farrag M, Huang H, Ossowski S, Haft S, Shriver L . Spinal Cord Transcriptomic and Metabolomic Analysis after Excitotoxic Injection Injury Model of Syringomyelia. J Neurotrauma. 2016; 34(3):720-733. DOI: 10.1089/neu.2015.4341. View

Jiang W, He F, Ding G, Wu J . Dopamine inhibits pyroptosis and attenuates secondary damage after spinal cord injury in female mice. Neurosci Lett. 2022; 792:136935. DOI: 10.1016/j.neulet.2022.136935. View

de Castro Jr R, BURNS C, McAdoo D, Romanic A . Metalloproteinase increases in the injured rat spinal cord. Neuroreport. 2000; 11(16):3551-4. DOI: 10.1097/00001756-200011090-00029. View

Chen Z, Ma Y, Guo H, Lu Z, Jin Q . Therapeutic efficacy of cyclosporin A against spinal cord injury in rats with hyperglycemia. Mol Med Rep. 2018; 17(3):4369-4375. PMC: 5802210. DOI: 10.3892/mmr.2018.8422. View

10.

Mann C, Lee J, Hillyer J, Stammers A, Tetzlaff W, Kwon B . Lack of robust neurologic benefits with simvastatin or atorvastatin treatment after acute thoracic spinal cord contusion injury. Exp Neurol. 2009; 221(2):285-95. DOI: 10.1016/j.expneurol.2009.11.006. View

11.

Fehlings M, Vaccaro A, Wilson J, Singh A, Cadotte D, Harrop J . Early versus delayed decompression for traumatic cervical spinal cord injury: results of the Surgical Timing in Acute Spinal Cord Injury Study (STASCIS). PLoS One. 2012; 7(2):e32037. PMC: 3285644. DOI: 10.1371/journal.pone.0032037. View

12.

Li J, Liu Y, Xu H, Fu Q . Nanoparticle-Delivered IRF5 siRNA Facilitates M1 to M2 Transition, Reduces Demyelination and Neurofilament Loss, and Promotes Functional Recovery After Spinal Cord Injury in Mice. Inflammation. 2016; 39(5):1704-17. DOI: 10.1007/s10753-016-0405-4. View

13.

Lin S, Zhou Z, Zhao H, Xu C, Guo Y, Gao S . TNF promotes M1 polarization through mitochondrial metabolism in injured spinal cord. Free Radic Biol Med. 2021; 172:622-632. DOI: 10.1016/j.freeradbiomed.2021.07.014. View

14.

Lin W, Chen W, Liu W, Xu Z, Zhang L . Sirtuin4 suppresses the anti-neuroinflammatory activity of infiltrating regulatory T cells in the traumatically injured spinal cord. Immunology. 2019; 158(4):362-374. PMC: 6856927. DOI: 10.1111/imm.13123. View

15.

Liu Z, Zhang H, Xia H, Wang B, Zhang R, Zeng Q . CD8 T cell-derived perforin aggravates secondary spinal cord injury through destroying the blood-spinal cord barrier. Biochem Biophys Res Commun. 2019; 512(2):367-372. DOI: 10.1016/j.bbrc.2019.03.002. View

16.

Casha S, Zygun D, McGowan M, Bains I, Yong V, Hurlbert R . Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury. Brain. 2012; 135(Pt 4):1224-36. DOI: 10.1093/brain/aws072. View

17.

Lee S, Rosen S, Weinstein P, van Rooijen N, Noble-Haeusslein L . Prevention of both neutrophil and monocyte recruitment promotes recovery after spinal cord injury. J Neurotrauma. 2011; 28(9):1893-907. PMC: 3172879. DOI: 10.1089/neu.2011.1860. View

18.

Noble L, Donovan F, Igarashi T, Goussev S, Werb Z . Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci. 2002; 22(17):7526-35. PMC: 2792199. View

19.

Song J, Hu Y, Li H, Huang X, Zheng H, Hu Y . miR-1303 regulates BBB permeability and promotes CNS lesions following CA16 infections by directly targeting MMP9. Emerg Microbes Infect. 2018; 7(1):155. PMC: 6143596. DOI: 10.1038/s41426-018-0157-3. View

20.

Norden D, Qatanani A, Bethea J, Jiang J . Chronic spinal cord injury impairs primary CD8 T cell antiviral immunity but does not affect generation or function of memory CD8 T cells. Exp Neurol. 2019; 317:298-307. DOI: 10.1016/j.expneurol.2019.03.010. View